MGY825

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MGY825, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]